Flavonoids from fruit and vegetables: A focus on cardiovascular risk factors

Current Atherosclerosis Reports

Volumn 15, Issue 12, 2013, Pages

  Toh, J Y ^a   Tan, Verena M H ^a   Lim, Paul C Y ^b   Lim, S T ^b   Chong, Mary F F ^a  

^a AGENCY FOR SCIENCE   (Singapore)

^b DEPARTMENT OF CARDIOLOGY   (Singapore)

Author keywords

Blood lipids; Blood pressure; Cardiovascular risk; Flavonoids; Fruit and vegetables; Vascular function

Indexed keywords

ANTHOCYANIN; APPLE FLAVONOID; ATORVASTATIN; AURANTIIN; BERRY FLAVONOID; BIOFLAVONOID; BIOLOGICAL MARKER; CRANBERRY EXTRACT; EPICATECHIN; FLAVAN DERIVATIVE; FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOID; FLAVONOL DERIVATIVE; FLUINDOSTATIN; HESPERETIN; HESPERIDIN; ISOFLAVONE DERIVATIVE; NARINGENIN; ONION FLAVONOID; PLACEBO; POLYPHENOL; PRAVASTATIN; QUERCETIN; SIMVASTATIN; UNCLASSIFIED DRUG; PLANT EXTRACT;

ANTIOXIDANT ACTIVITY; APPLE; APPLE JUICE; ARTICLE; BERRY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RESPONSE; CARDIOVASCULAR RISK; CRANBERRY JUICE; DIETARY INTAKE; DRUG BIOAVAILABILITY; DRUG MECHANISM; FOOD DRUG INTERACTION; GRAPEFRUIT JUICE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPID BLOOD LEVEL; METABOLIC SYNDROME X; MORTALITY; ONION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; RISK REDUCTION; STRAWBERRY; ANIMAL; CHEMISTRY; FRUIT; REVIEW; RISK FACTOR; VEGETABLE;

ANIMALS; CARDIOVASCULAR DISEASES; FLAVONOIDS; FRUIT; HUMANS; PLANT EXTRACTS; RISK FACTORS; VEGETABLES;

EID: 84890535643     PISSN: 15233804     EISSN: 15346242     Source Type: Journal    
DOI: 10.1007/s11883-013-0368-y     Document Type: Article

References (55)

1. •• Corcoran MP, McKay DL, Blumberg JB. Flavonoid basics: chemistry, sources, mechanisms of action, and safety. J Nutr Gerontol Geriatr. 2012;31(3):176-89. doi: 10.1080/21551197.2012.698219. This article offers comprehensive information on flavonoids, along with details on flavonoid content in various important food sources.
2. Hertog MG, Feskens EJ, Hollman PC, et al. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen elderly study. Lancet. 1993;342(8878):1007-11.
3. Mink PJ, Scrafford CG, Barraj LM, et al. Flavonoid intake and cardiovascular disease mortality: A prospective study in postmenopausal women. Am J Clin Nutr. 2007;85(3):895-909.
4. Mursu J, Nurmi T, Tuomainen TP, et al. The intake of flavonoids and carotid atherosclerosis: The Kuopio ischaemic heart disease risk factor study. Br J Nutr. 2007;98(4):814-8. doi: 10.1017/S0007114507744410.
5. Cassidy A, O'Reilly EJ, Kay C, et al. Habitual intake of flavonoid subclasses and incident hypertension in adults. Am J Clin Nutr. 2011;93(2):338-47. doi: 10.3945/ajcn.110.006783.
6. Kay CD, Hooper L, Kroon PA, et al. Relative impact of flavonoid composition, dose and structure on vascular function: A systematic review of randomised controlled trials of flavonoid-rich food products. Mol Nutr Food Res. 2012;56(11):1605-16. doi: 10.1002/mnfr.201200363.
7. Mulvihill EE, Huff MW. Antiatherogenic properties of flavonoids: Implications for cardiovascular health. Can J Cardiol. 2010;26(A):17A-21A.
8. El Haouari M, Rosado JA. Modulation of platelet function and signaling by flavonoids. Mini Rev Med Chem. 2011;11(2):131-42.
9. Siasos G, Tousoulis D, Tsigkou V, et al. Flavonoids in atherosclerosis: An overview of their mechanisms of action. Curr Med Chem. 2013;20(21):2641-60.
10. Gresele P, Cerletti C, Guglielmini G, et al. Effects of resveratrol and other wine polyphenols on vascular function: An update. J Nutr Biochem. 2011;22(3):201-11. doi: 10.1016/j.jnutbio.2010.07.004.
11. Heiss C, Schroeter H, Balzer J, et al. Endothelial function, nitric oxide, and cocoa flavanols. J Cardiovasc Pharmacol. 2006;47(2):S128-35. discussion S72-6.
12. Grassi D, Desideri G, Croce G, et al. Flavonoids, vascular function and cardiovascular protection. Curr Pharm Des. 2009;15(10):1072-84.
13. Dauchet L, Amouyel P, Dallongeville J. Fruits, vegetables and coronary heart disease. Nat Rev Cardiol. 2009;6(9):599-608. doi: 10.1038/nrcardio.2009. 131.
14. Lusis AJ. Atherosclerosis. Nature. 2000;407(6801):233-41. doi: 10.1038/35025203.
15. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context. Lancet. 1990;335(8693):827-38.
16. Aviram M. Hyperlipidaemia and cardiovascular disease. Curr Opin Lipidol. 2007;18(4):473-5. doi: 10.1097/MOL.0b013e32823bcb28.
17. Vita JA, Keaney Jr JF. Endothelial function: A barometer for cardiovascular risk? Circulation. 2002;106(6):640-2.
18. Vinson JA, Su X, Zubik L, Bose P. Phenol antioxidant quantity and quality in foods: Fruits. J Agric Food Chem. 2001;49(11):5315-21.
19. Knekt P, Jarvinen R, Seppanen R, et al. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol. 1997;146(3):223-30.
20. Bondonno CP, Yang X, Croft KD, et al. Flavonoid-rich apples and nitrate-rich spinach augment nitric oxide status and improve endothelial function in healthy men and women: a randomized controlled trial. Free Radic Biol Med. 2012;52(1):95-102. doi: 10.1016/j.freeradbiomed.2011.09.028.
21. Auclair S, Chironi G, Milenkovic D, et al. The regular consumption of a polyphenol-rich apple does not influence endothelial function: A randomised double-blind trial in hypercholesterolemic adults. Eur J Clin Nutr. 2010;64(10):1158-65. doi: 10.1038/ejcn.2010.135.
22. Vafa MR, Haghighatjoo E, Shidfar F, et al. Effects of apple consumption on lipid profile of hyperlipidemic and overweight men. Int J Prev Med. 2011;2(2):94-100.
23. Nagasako-Akazome Y, Kanda T, Ohtake Y, et al. Apple polyphenols influence cholesterol metabolism in healthy subjects with relatively high body mass index. J Oleo Sci. 2007;56(8):417-28.
24. • Ravn-Haren G, Dragsted LO, Buch-Andersen T, et al. Intake of whole apples or clear apple juice has contrasting effects on plasma lipids in healthy volunteers. Eur J Nutr. 2012. doi: 10.1007/s00394-012-0489-z. This article looks at the effects of food processing on the flavonoid content of apples and the subsequent effect on CVD risk factors. The results revealed that besides flavonoids, the lack of soluble pectins in clear apple juice as compared with whole apples also had a role to play in improving the lipid profile of the subjects.
25. Tripoli E, Guardia ML, Giammanco S, et al. Citrus flavonoids: molecular structure, biological activity and nutritional properties: A review. Food Chem. 2007;104(2):466-79. doi: 10.1016/j.foodchem.2006.11.054.
26. Morand C, Dubray C, Milenkovic D, et al. Hesperidin contributes to the vascular protective effects of orange juice: A randomized crossover study in healthy volunteers. Am J Clin Nutr. 2011;93(1):73-80. doi: 10.3945/ajcn.110. 004945.
27. Rizza S, Muniyappa R, Iantorno M, et al. Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome. J Clin Endocrinol Metab. 2011;96(5):E782-92. doi: 10.1210/jc.2010-2879.
28. Gorinstein S, Caspi A, Libman I, et al. Preventive effects of diets supplemented with sweetie fruits in hypercholesterolemic patients suffering from coronary artery disease. Prev Med. 2004;38(6):841-7. doi: 10.1016/j.ypmed.2003. 12.021.
29. Gorinstein S, Caspi A, Libman I, et al. Red grapefruit positively influences serum triglyceride level in patients suffering from coronary atherosclerosis: studies in vitro and in humans. J Agric Food Chem. 2006;54(5):1887-92. doi: 10.1021/jf058171g.
30. Craig WJ. Phytochemicals: Guardians of our health. J Am Diet Assoc. 1997;97(10 Suppl 2):S199-204.
31. Jung UJ, Kim HJ, Lee JS, et al. Naringin supplementation lowers plasma lipids and enhances erythrocyte antioxidant enzyme activities in hypercholesterolemic subjects. Clin Nutr. 2003;22(6):561-8.
32. Demonty I, Lin Y, Zebregs YE, et al. The citrus flavonoids hesperidin and naringin do not affect serum cholesterol in moderately hypercholesterolemic men and women. J Nutr. 2010;140(9):1615-20. doi: 10.3945/jn.110.124735.
33. Backman WD, Bakhai A. A more balanced approach to drug-grapefruit juice interactions. BMJ. 2013;346:f1073. doi: 10.1136/bmj.f1073.
34. Basu A, Rhone M, Lyons TJ. Berries: Emerging impact on cardiovascular health. Nutr Rev. 2010;68(3):168-77. doi: 10.1111/j.1753-4887.2010.00273.x.
35. Erlund I, Koli R, Alfthan G, et al. Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol. Am J Clin Nutr. 2008;87(2):323-31.
36. Basu A, Du M, Leyva MJ, et al. Blueberries decrease cardiovascular risk factors in obese men and women with metabolic syndrome. J Nutr. 2010;140(9):1582-7. doi: 10.3945/jn.110.124701.
37. Jennings A, Welch AA, Fairweather-Tait SJ, et al. Higher anthocyanin intake is associated with lower arterial stiffness and central blood pressure in women. Am J Clin Nutr. 2012;96(4):781-8. doi: 10.3945/ajcn.112.042036.
38. Karlsen A, Retterstol L, Laake P, et al. Anthocyanins inhibit nuclear factor-kappaB activation in monocytes and reduce plasma concentrations of pro-inflammatory mediators in healthy adults. J Nutr. 2007;137(8):1951-4.
39. Ruel G, Pomerleau S, Couture P, et al. Low-calorie cranberry juice supplementation reduces plasma oxidized LDL and cell adhesion molecule concentrations in men. Br J Nutr. 2008;99(2):352-9. doi: 10.1017/ S0007114507811986.
40. • Basu A, Fu DX, Wilkinson M, et al. Strawberries decrease atherosclerotic markers in subjects with metabolic syndrome. Nutr Res. 2010;30(7):462-9. doi: 10.1016/j.nutres.2010.06.016. The article discusses several aspects of metabolic syndrome, and provides important findings that support the benefits of strawberries in improving metabolic syndrome.
41. Lee IT, Chan YC, Lin CW, et al. Effect of cranberry extracts on lipid profiles in subjects with type 2 diabetes. Diabet Med. 2008;25(12):1473-7. doi: 10.1111/j.1464-5491.2008.02588.x.
42. Larson AJ, Symons JD, Jalili T. Therapeutic potential of quercetin to decrease blood pressure: Review of efficacy and mechanisms. Adv Nutr. 2012;3(1):39-46. doi: 10.3945/an.111.001271.
43. Edwards RL, Lyon T, Litwin SE, et al. Quercetin reduces blood pressure in hypertensive subjects. J Nutr. 2007;137(11):2405-11.
44. Egert S, Bosy-Westphal A, Seiberl J, et al. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: A double-blinded, placebo-controlled cross-over study. Br J Nutr. 2009;102(7):1065-74. doi: 10.1017/S0007114509359127.
45. Loke WM, Hodgson JM, Proudfoot JM, et al. Pure dietary flavonoids quercetin and (-)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am J Clin Nutr. 2008;88(4):1018-25.
46. Al-Solaiman Y, Jesri A, Mountford W, et al. DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre. J Hum Hypertens. 2010;24(4):237-46.
47. Long KZ, Santos JI, Rosado JL, et al. Vitamin A supplementation modifies the association between mucosal innate and adaptive immune responses and resolution of enteric pathogen infections. Am J Clin Nutr. 2011;93(3):578-85. doi: 10.3945/ajcn.110.003913.
48. Latsios G, Tousoulis D, Androulakis E, et al. MicroRNAs in the diagnosis and treatment of unstable angina. Cur Top Med Chem. 2013;13(13):1596-604.
49. Tousoulis D, Androulakis E, Papageorgiou N, et al. Novel biomarkers assessing endothelial dysfunction: role of miRNAs. Curr Top Med Chem. 2013;13(13):1518-26.
50. Siasos G, Chrysohoou C, Tousoulis D, et al. The impact of physical activity on endothelial function in middle-aged and elderly subjects: The Ikaria study. Hell J Cardiol. 2013;54(2):94-101.
51. Tousoulis D, Siasos G, Zaromitidou M, et al. The impact of CYP2C19 genotype on cardiovascular events and platelet reactivity in patients with coronary artery disease receiving clopidogrel. Int J Cardiol. 2013. doi: 10.1016/j.ijcard.2013.01.040.
52. Baldrick FR, Woodside JV, Elborn JS, et al. Biomarkers of fruit and vegetable intake in human intervention studies: A systematic review. Crit Rev Food Sci Nutr. 2011;51(9):795-815. doi: 10.1080/10408398.2010.482217.
53. Erlund I, Silaste ML, Alfthan G, et al. Plasma concentrations of the flavonoids hesperetin, naringenin and quercetin in human subjects following their habitual diets, and diets high or low in fruit and vegetables. Eur J Clin Nutr. 2002;56(9):891-8. doi: 10.1038/sj.ejcn.1601409.
54. Beecher GR. Overview of dietary flavonoids: Nomenclature, occurrence and intake. J Nutr. 2003;133(10):3248S-54S.
55. Hooper L, Kroon PA, Rimm EB, et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: A meta-analysis of randomized controlled trials. Am J Clin Nutr. 2008;88(1):38-50.